Key points are not available for this paper at this time.
Serotonin (5-hydroxytryptamine; 5-HT) has been implicated in a large number of psychophysiologic processes including the regulation of sleep, appetite, mood, aggression, perception, memory, and anxiety. To mediate this large array of physiologic processes, at least 14 separate 5-HT receptors have evolved, which are divided into seven main families. Not surprisingly, alterations of 5-HT receptor activity have been shown to occur in many psychiatric diseases including anxiety, depression, eating disorders, schizophrenia, personality disorders, and many drug-induced psychotic states. Additionally, a number of effective psychopharmacologic agents for diseases as diverse as schizophrenia and anxiety have been developed which either specifically alter brain levels of serotonin or bind to 5-HT receptor subtypes. This review article summarizes recent advances in the burgeoning field of serotonin receptor pharmacology and integrates this information into a coherent perspective on the importance of serotonergic agents for clinical psychiatry.
Building similarity graph...
Analyzing shared references across papers
Loading...
Bryan Roth
University of North Carolina at Chapel Hill
Annals of Clinical Psychiatry
Case Western Reserve University
University School
Building similarity graph...
Analyzing shared references across papers
Loading...
Bryan Roth (Wed,) studied this question.
synapsesocial.com/papers/6a1003ecd13714ec96ff0035 — DOI: https://doi.org/10.3109/10401239409148985